Roberto Chiesa

Cited by

	All	Since 2019
Citations	7392	1593
h-index	42	22
i10-index	72	47

340

170

255

1993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202426 80 89 106 134 178 163 164 194 212 213 231 281 235 273 321 317 262 331 304 335 242 246 269 294 240 276 292 292 248 259 222

Public access

View all

41 articles

4 articles

available

not available

Based on funding mandates

Co-authors

Gianluigi ForloniHead of Neuroscience Department IRCCS Mario Negri, MilanVerified email at marionegri.it
Mario SalmonaCapo del Dipartimento di Biochimica e Farmacologia MolecolareVerified email at marionegri.it
Fabrizio TagliaviniFondazione IRCCS Istituto Neurologico Carlo Besta, MilanoVerified email at istituto-besta.it
Emiliano BiasiniDepartment of Cellular, Computational & Integrative Biology (CIBIO), University of Trento, ITALYVerified email at unitn.it
Marco GobbiIstituto di Ricerche Farmacologiche Mario Negri IRCCSVerified email at marionegri.it
Matteo StravalaciFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoVerified email at policlinico.mi.it
Valentina BonettoCoordinator of the Research Center for ALS, Head of the Laboratory of Translational BiomarkersVerified email at marionegri.it
Luca ImeriAssociate Professor of Human Physiology, University of Milan Medical School, Milan, ItalyVerified email at unimi.it
Antonio MasoneColumbia University Irving Medical Center - Taub InstituteVerified email at cumc.columbia.edu
Edoardo MicottiDept. of Neuroscience - Mario Negri Institute for Pharmacological ResearchVerified email at marionegri.it
Antonio MigheliUniversity of TurinVerified email at unito.it
Elisa R ZanierDepartment of Acute Brain and Cardiovascular Injury, Mario Negri Institute IRCCSVerified email at marionegri.it
Maria Grazia De SimoniMario NegriVerified email at marionegri.it
Francesca PischiuttaIRCCS - Istituto di Ricerche Farmacologiche Mario NegriVerified email at marionegri.it
Giorgio GiacconeFondazione IRCCS Istituto Neurologica BestaVerified email at istituto-besta.it
William StewartQueen Elizabeth University Hospital Glasgow; University of Glasgow; University of PennsylvaniaVerified email at glasgow.ac.uk
Annamaria VezzaniIRCCS-Istituto di Ricerche Farmacologiche Mario NegriVerified email at marionegri.it
Sylvain LehmannProfessor of Biochemistry, Montpellier UniversityVerified email at umontpellier.fr
Michela MatteoliCNR Istituto di Neuroscienze e IRCCS HumanitasVerified email at in.cnr.it
Annette C DolphinProfessor of Pharmacology, University College LondonVerified email at ucl.ac.uk

Roberto Chiesa

Laboratory of Prion Neurobiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan

Verified email at marionegri.it - Homepage

Prions Alzheimer's disease Marinesco-Sjögren syndrome


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Neurotoxicity of a prion protein fragment G Forloni, N Angeretti, R Chiesa, E Monzani, M Salmona, O Bugiani, ... Nature 362 (6420), 543-546, 1993	1156	1993
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein C Balducci, M Beeg, M Stravalaci, A Bastone, A Sclip, E Biasini, L Tapella, ... Proceedings of the National Academy of Sciences 107 (5), 2295-2300, 2010	606	2010
Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35 G Forloni, R Chiesa, S Smiroldo, L Verga, M Salmona, F Tagliavini, ... Neuroreport 4 (5), 523-526, 1993	424	1993
Neurological illness in transgenic mice expressing a prion protein with an insertional mutation R Chiesa, P Piccardo, B Ghetti, DA Harris Neuron 21 (6), 1339-1351, 1998	387	1998
Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation B Drisaldi, RS Stewart, C Adles, LR Stewart, E Quaglio, E Biasini, L Fioriti, ... Journal of Biological Chemistry 278 (24), 21732-21743, 2003	286	2003
Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105–125 A Li, HM Christensen, LR Stewart, KA Roth, R Chiesa, DA Harris The EMBO journal 26 (2), 548-558, 2007	259	2007
Evidence for a six-transmembrane domain structure of presenilin 1 S Lehmann, R Chiesa, DA Harris Journal of Biological Chemistry 272 (18), 12047-12051, 1997	223	1997
Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform E Quaglio, R Chiesa, DA Harris Journal of Biological Chemistry 276 (14), 11432, 2001	222	2001
Prion diseases: what is the neurotoxic molecule? R Chiesa, DA Harris Neurobiology of disease 8 (5), 743-763, 2001	210	2001
Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation R Chiesa, B Drisaldi, E Quaglio, A Migheli, P Piccardo, B Ghetti, DA Harris Proceedings of the National Academy of Sciences 97 (10), 5574-5579, 2000	193	2000
Molecular distinction between pathogenic and infectious properties of the prion protein R Chiesa, P Piccardo, E Quaglio, B Drisaldi, SL Si-Hoe, M Takao, B Ghetti, ... Journal of virology 77 (13), 7611-7622, 2003	179	2003
Induction of a transmissible tau pathology by traumatic brain injury ER Zanier, I Bertani, E Sammali, F Pischiutta, MA Chiaravalloti, ... Brain 141 (9), 2685-2699, 2018	152	2018
Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170-and 180-kDa isozymes C Negri, R Chiesa, A Cerino, M Bestagno, C Sala, N Zini, NM Maraldi, ... Experimental cell research 200 (2), 452-459, 1992	151	1992
Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein A Orsi, L Fioriti, R Chiesa, R Sitia Journal of Biological Chemistry 281 (41), 30431-30438, 2006	142	2006
Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations L Fioriti, S Dossena, LR Stewart, RS Stewart, DA Harris, G Forloni, ... Journal of Biological Chemistry 280 (12), 11320-11328, 2005	138	2005
A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy G Forloni, R Del Bo, N Angeretti, R Chiesa, S Smiroldo, R Doni, ... European Journal of Neuroscience 6 (9), 1415-1422, 1994	136	1994
Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model S Dossena, L Imeri, M Mangieri, A Garofoli, L Ferrari, A Senatore, ... Neuron 60 (4), 598-609, 2008	130	2008
Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease R Chiesa, P Piccardo, S Dossena, L Nowoslawski, KA Roth, B Ghetti, ... Proceedings of the National Academy of Sciences 102 (1), 238-243, 2005	115	2005
Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells E Biasini, L Fioriti, I Ceglia, R Invernizzi, A Bertoli, R Chiesa, G Forloni Journal of neurochemistry 88 (3), 545-553, 2004	90	2004
Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC α2δ-1 subunit A Senatore, S Colleoni, C Verderio, E Restelli, R Morini, SB Condliffe, ... Neuron 74 (2), 300-313, 2012	80	2012

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors